MJN110

Overview

MJN110 is an orally active and selective monoacylglycerol lipase ( MAGL ) inhibitor with IC 50 s of 9.1 nM and 2.1 nM for hMAGL and 2-arachidonoylglycerol (2-AG), respectively. MJN110 produces opioid-sparing effects and displays strong antihyperalgesic activity.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > MAGL

Product Information

• Catalog No.: HY-117474
• CAS No.: 1438416-21-7
• Molecular Formula: C22H21Cl2N3O4
• Molecular Weight: 462.33
• Purity: 99.83%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (5.41 mM); Clear solution
• Availability: In-stock

Source

Original product source